Biogen's total assets for Q3 2024 were $28.31B, an increase of 5.63% from the previous quarter. BIIB total liabilities were $11.95B for the fiscal quarter, a 9.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.